Neil Palmisiano

Ipilimumab, nivolumab, and brentuximab vedotin combination therapies in patients with relapsed or refractory Hodgkin lymphoma: phase 1 results of an open-label, multicentre, phase 1/2 trial

Catherine Diefenbach, Fangxin Hong, Richard F. Ambinder et al. · The Lancet Haematology · 2020 · 137 citations · Full text

Phase 1/2, Lymphoid Neoplasia, Oncology +10

Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission

Armin Rashidi, Mehdi Hamadani, Mei-Jie Zhang et al. · Blood Advances · 2019 · 127 citations · Full text

Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers

Andrew M. Evens, Alexey V. Danilov, Deepa Jagadeesh et al. · Blood · 2021 · 122 citations · Full text

Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia

Matthew J. Wieduwilt, Leland Metheny, Mei‐Jie Zhang et al. · Blood Advances · 2021 · 74 citations · Full text

Blimp-1 impairs T cell function via upregulation of TIGIT and PD-1 in patients with acute myeloid leukemia

Liuluan Zhu, Yaxian Kong, Jianhong Zhang et al. · Journal of Hematology & Oncology · 2017 · 65 citations · Full text